Abstract
ObjectiveTo report the first case of a patient with refractory childhood-onset SLE successfully treated with anti-CD19 CAR-T cell therapy.MethodsA single infusion of fresh, autologous second-generation anti-CD19 CAR-T product (lentivirus) manufactured...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
